1,759
Views
26
CrossRef citations to date
0
Altmetric
Research Article

Preclinical dynamic 18F-FDG PET – tumor characterization and radiotherapy response assessment by kinetic compartment analysis

, , , , , , , & show all
Pages 914-921 | Received 17 May 2010, Accepted 30 May 2010, Published online: 13 Sep 2010

References

  • Greco C, Ling C. Broadening the scope of image-guided radiotherapy (IGRT). Acta Oncol 2008;47:1193–200.
  • Bjurberg M, Gustavsson A, Ohlsson T, Brun T. FDG-PET in the detection of residual disease and relapse in patients with Hodgkin's lymphoma. Experience from at Swedish centre. Acta Oncol 2006;45:743–9.
  • Bomanji JB, Costa DC, Ell PJ. Clinical role of positron emission tomography in oncology. Lancet Oncol 2001;2:157–64.
  • Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, . Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 2008;49:480–508.
  • Warburg O. On the origin of cancer cells. Science 1956;123:309–14.
  • Plathow C, Weber WA. Tumor cell metabolism imaging. J Nucl Med 2008;49(Suppl 2):S43–S63.
  • Zhao S, Kuge Y, Mochizuki T, Takahashi T, Nakada K, Sato M, . Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor. J Nucl Med 2005;46:675–82.
  • Krak NC, Boellaard R, Hoekstra OS, Twisk JW, Hoekstra CJ, Lammertsma AA. Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial. Eur J Nucl Med Mol Imaging 2005;32:294–301.
  • Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: A simulation study. J Nucl Med 2004;45:1519–27.
  • Keyes JW Jr. SUV: Standard uptake or silly useless value? J Nucl Med 1995;36:1836–9.
  • Sovik A, Malinen E, Olsen DR. Strategies for biologic image-guided dose escalation: A review. Int J Radiat Oncol Biol Phys 2009;73:650–8.
  • Kumar R, Dhanpathi H, Basu S, Rubello D, Fanti S, Alavi A. Oncologic PET tracers beyond [(18)F]FDG and the novel quantitative approaches in PET imaging. Q J Nucl Med Mol Imaging 2008;52:50–65.
  • Pantaleo MA, Nannini M, Maleddu A, Fanti S, Ambrosini V, Nanni C, . Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy. Cancer Treat Rev 2008;34:103–21.
  • Wainstein MA, He F, Robinson D, Kung HJ, Schwartz S, Giaconia JM, . CWR22: Androgen-dependent xenograft model derived from a primary human prostatic carcinoma. Cancer Res 1994;54:6049–52.
  • Nagabhushan M, Miller CM, Pretlow TP, Giaconia JM, Edgehouse NL, Schwartz S, . CWR22: The first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. Cancer Res 1996;56:3042–6.
  • Qi J, Leahy RM. Resolution and noise properties of MAP reconstruction for fully 3-D PET. IEEE Trans Med Imaging 2000;19:493–506.
  • Qi J, Leahy RM, Cherry SR, Chatziioannou A, Farquhar TH. High-resolution 3D Bayesian image reconstruction using the microPET small-animal scanner. Phys Med Biol 1998; 43:1001–13.
  • Markwardt CB. Non-linear least squares fitting in IDL with MPFIT. “Astronomical” data analysis software and systems XVIII”, editorsBohlender D, Dowler P, Durand D. ASP Conference Series 2008; 411. Quebec, Canada. 251–4.
  • Kamasak ME, Bouman CA, Morris ED, Sauer K. Direct reconstruction of kinetic parameter images from dynamic PET data. IEEE Trans Med Imaging 2005;24:636–50.
  • Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method. Ann Neurol 1979;6:371–88.
  • Pugachev A, Ruan S, Carlin S, Larson SM, Campa J, Ling CC, . Dependence of FDG uptake on tumor microenvironment. Int J Radiat Oncol Biol Phys 2005;62: 545–53.
  • Tseng J, Dunnwald LK, Schubert EK, Link JM, Minoshima S, Muzi M, . 18F-FDG kinetics in locally advanced breast cancer: Correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy. J Nucl Med 2004;45:1829–37.
  • Baker DG, Krochak RJ. The response of the microvascular system to radiation: A review. Cancer Invest 1989;7:287–94.
  • Dierckx RA, Van De Wiele C. FDG uptake, a surrogate of tumour hypoxia? Eur J Nucl Med Mol Imaging 2008;35: 1544–9.
  • Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 1999;24:68–72.
  • Clavo AC, Brown RS, Wahl RL. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med 1995;36:1625–32.
  • Burgman P, Odonoghue JA, Humm JL, Ling CC. Hypoxia-induced increase in FDG uptake in MCF7 cells. J Nucl Med 2001;42:170–5.
  • Kim Y, Tomé WA. Dose-painting IMRT optimization using biological parameters. Acta Oncol 2010 (in press).
  • Røe K, Muren LP, Rørvik J, Olsen DR, Dahl O, Bakke A, . Dynamic contrast enhanced magnetic resonance imaging of bladder cancer and implications for biological image-adapted radiotherapy. Acta Oncol 2008;47:1257–64.
  • Toma-Dasu I, Dasu A, Brahme A. Dose prescription and optimisation based on tumour hypoxia. Acta Oncol 2009; 48:1181–92.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.